These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 34985768)
21. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients. Chen B; Liu S; Gan L; Wang J; Hu B; Xu H; Tong R; Yang H; Cristina I; Xue J; Hu X; Lu Y Cancer Biol Ther; 2018 Jan; 19(1):76-86. PubMed ID: 29257923 [TBL] [Abstract][Full Text] [Related]
22. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy. Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468 [TBL] [Abstract][Full Text] [Related]
23. FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer. Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S Oncogene; 2018 Sep; 37(39):5340-5354. PubMed ID: 29858603 [TBL] [Abstract][Full Text] [Related]
24. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression. Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789 [TBL] [Abstract][Full Text] [Related]
25. Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer. Granata A; Nicoletti R; Tinaglia V; De Cecco L; Pisanu ME; Ricci A; Podo F; Canevari S; Iorio E; Bagnoli M; Mezzanzanica D Br J Cancer; 2014 Jan; 110(2):330-40. PubMed ID: 24281000 [TBL] [Abstract][Full Text] [Related]
26. FGFR1 is an independent prognostic factor and can be regulated by miR-497 in gastric cancer progression. Xie G; Ke Q; Ji YZ; Wang AQ; Jing M; Zou LL Braz J Med Biol Res; 2018 Nov; 52(1):e7816. PubMed ID: 30484492 [TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers. Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085 [TBL] [Abstract][Full Text] [Related]
28. FGFR1 abrogates inhibitory effect of androgen receptor concurrent with induction of androgen-receptor variants in androgen receptor-negative prostate tumor epithelial cells. Kobayashi M; Huang Y; Jin C; Luo Y; Okamoto T; Wang F; McKeehan WL Prostate; 2011 Nov; 71(15):1691-700. PubMed ID: 21446013 [TBL] [Abstract][Full Text] [Related]
29. A rare premalignant prostate tumor epithelial cell syndecan-1 forms a fibroblast growth factor-binding complex with progression-promoting ectopic fibroblast growth factor receptor 1. Wu X; Kan M; Wang F; Jin C; Yu C; McKeehan WL Cancer Res; 2001 Jul; 61(13):5295-302. PubMed ID: 11431373 [TBL] [Abstract][Full Text] [Related]
30. Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. Tomlinson DC; Lamont FR; Shnyder SD; Knowles MA Cancer Res; 2009 Jun; 69(11):4613-20. PubMed ID: 19458078 [TBL] [Abstract][Full Text] [Related]
31. FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior. Chioni AM; Grose R J Cell Biol; 2012 Jun; 197(6):801-17. PubMed ID: 22665522 [TBL] [Abstract][Full Text] [Related]
32. Novel mechanisms of fibroblast growth factor receptor 1 regulation by extracellular matrix protein anosmin-1. Hu Y; Guimond SE; Travers P; Cadman S; Hohenester E; Turnbull JE; Kim SH; Bouloux PM J Biol Chem; 2009 Oct; 284(43):29905-20. PubMed ID: 19696444 [TBL] [Abstract][Full Text] [Related]
33. Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation. Miyake T; Parsons SJ Oncogene; 2012 Mar; 31(11):1431-41. PubMed ID: 21822308 [TBL] [Abstract][Full Text] [Related]
34. FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway. Ji W; Yu Y; Li Z; Wang G; Li F; Xia W; Lu S Oncotarget; 2016 Mar; 7(12):15118-34. PubMed ID: 26936993 [TBL] [Abstract][Full Text] [Related]
35. Activation of the FGF2/FGFR1 autocrine loop for cell proliferation and survival in uveal melanoma cells. Lefèvre G; Babchia N; Calipel A; Mouriaux F; Faussat AM; Mrzyk S; Mascarelli F Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1047-57. PubMed ID: 19029025 [TBL] [Abstract][Full Text] [Related]
36. Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia. Wang F; McKeehan K; Yu C; Ittmann M; McKeehan WL Prostate; 2004 Jan; 58(1):1-12. PubMed ID: 14673947 [TBL] [Abstract][Full Text] [Related]
37. Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate. Jin C; McKeehan K; Guo W; Jauma S; Ittmann MM; Foster B; Greenberg NM; McKeehan WL; Wang F Cancer Res; 2003 Dec; 63(24):8784-90. PubMed ID: 14695195 [TBL] [Abstract][Full Text] [Related]
38. Calcitriol downregulates fibroblast growth factor receptor 1 through histone deacetylase activation in HL-1 atrial myocytes. Lee TW; Lee TI; Lin YK; Kao YH; Chen YJ J Biomed Sci; 2018 May; 25(1):42. PubMed ID: 29776409 [TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor receptor 5 (FGFR5) is a co-receptor for FGFR1 that is up-regulated in beta-cells by cytokine-induced inflammation. Regeenes R; Silva PN; Chang HH; Arany EJ; Shukalyuk AI; Audet J; Kilkenny DM; Rocheleau JV J Biol Chem; 2018 Nov; 293(44):17218-17228. PubMed ID: 30217817 [TBL] [Abstract][Full Text] [Related]
40. Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer. Hu Y; Feng X; Mintz A; Petty WJ; Hsu W Oncotarget; 2016 Dec; 7(52):87124-87135. PubMed ID: 27893433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]